Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesRobotic-Assisted Radical Prostatectomy in Patients Receiving Chronic Anticoagulation Therapy: Role of Perioperative Bridging
Urology, 12/05/08
Krane LS et al. - The results of the study have shown that RARP can be performed safely in patients requiring CAT, with and without bridging therapy. Patients in protocol 2 had greater transfusion rates, but this did not translate into increased complications or readmissions.
| Previous Article | Next Article |
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?
Cancer, 06/04/09
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 06/22/09
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Journal of Cancer Research & Clinical Oncology, 06/03/09
Today in Surgical Technique...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 06/22/09
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Journal of Cancer Research & Clinical Oncology, 06/03/09
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 05/13/09
Article Search
Sponsor